- Patent Title: Methods for treating pancreatic cancer using combination therapies
-
Application No.: US15241128Application Date: 2016-08-19
-
Publication No.: US09717724B2Publication Date: 2017-08-01
- Inventor: Eliel Bayever , Navreet Dhindsa , Jonathan Basil Fitzgerald , Peter Laivins , Victor Moyo , Clet Niyikiza , Jaeyeon Kim
- Applicant: IPSEN BIOPHARM LTD.
- Applicant Address: GB Wrexham
- Assignee: Ipsen Biopharm Ltd.
- Current Assignee: Ipsen Biopharm Ltd.
- Current Assignee Address: GB Wrexham
- Agency: Honigman Miller Schwartz and Cohn LLP
- Agent Cynthia M. Bott; Jonathan P. O'Brien
- Main IPC: A01N43/00
- IPC: A01N43/00 ; A61K31/33 ; A61K38/00 ; A61P35/00 ; A61K31/4745 ; A61K31/573 ; A61K45/06 ; A61K31/513 ; A61K31/517 ; A61K9/00 ; A61K9/127 ; A61K31/519 ; A61K47/28 ; A61K47/24 ; A61K47/26
Abstract:
Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (MM-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (MM-398) is co-administered with 5-fluorouracil and leucovorin.
Public/Granted literature
- US20160375004A1 Methods for Treating Pancreatic Cancer Using Combination Therapies Public/Granted day:2016-12-29
Information query
IPC分类:
